Dosimetry during adjuvant I therapy in patients with differentiated thyroid cancer-clinical implications.

The activity of radioiodine (I) used in adjuvant therapy for thyroid cancer ranges between 30 mCi (1.1 GBq) and 150 mCi (5.5 GBq).